Clinical Significance:

ALT/GPT is present in high concentration in liver and to a lesser extent in kidney, heart, skeletal muscle, pancreas, spleen and lung. Increased levels of ALT/GPT however is generally a result of liver disease associated with some degree of hepatic necrosis such as cirrhosis, viral or toxic hepatitis and obstructive jaundi­ce. Characteristically ALT/GPT is generally higher than AST/GPT in acute viral or toxic hepatitis, whereas for most patients with chronic hepatic disease, ALT/GPT levels are generally lower than AST/GPT levels. Elevated ALT/GPT levels have also been found in extensive trauma and muscle disease, circulatory failure with shock, hypoxia, myocardial infarction and haemolytic disease.

Packaging Information:

Method	Type	PackSize	Produt Type
IFCC	Powder	5 x 6.5 ml	120206
IFCC	Powder	5 x 20 ml	120207
IFCC	Powder	10 x 50 ml	120208
IFCC	Liquixx	R1: 4 x 24 ml; R2: 4 x 6 ml	120903
IFCC	Liquixx	4 x 250 ml	120179